Track market-moving stories before they get noisy

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Paccar (PCAR - Free Report) , which belongs to the Zacks Automotive - Domestic industry, could be a great candidate to consider.

This truck maker has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 4.64%.

For the most recent quarter, Paccar was expected to post earnings of $1.33 per share, but it reported $1.43 per share instead, representing a surprise of 7.52%. For the previous quarter, the consensus estimate was $1.13 per share, while it actually produced $1.15 per share, a surprise of 1.77%.

Price and EPS Surprise

With this earnings history in mind, recent estimates have been moving higher for Paccar. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the company is positive, which is a great sign of an earnings beat, especially when you combine this metric with its nice Zacks Rank.

Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Paccar has an Earnings ESP of +1.04% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #2 (Buy), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on October 27, 2026.

With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.

Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.

Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Key Takeaways Zebra Technologies benefits from strong mobile computing, printing, machine vision and RFID demand.ZBRA's Q2 sales rose 25.9% in Connected Frontline and 13.5% in Asset Visibility & Automation.Free cash flow rose 25.3%, supporting investments and roughly $700 million in 2026 share repurchases. Zebra Technologies Corporation (ZBRA - Free Report) shares have popped 71.3% in the past six months, in line with the Zacks Manufacturing - Thermal Products industry’s rise while topping the S&P 500’s increase of 14.1%.

ZBRA is benefiting from broad demand across retail, manufacturing and healthcare, with mobile computing, printing, machine vision and RFID (radio frequency identification) supporting growth across both segments. Its integrated hardware, software and services portfolio is deepening customer adoption of automation and artificial intelligence (AI)-enabled workflows, while Elo Touch and Photoneo expand its addressable opportunities. Healthy cash generation continues to support share repurchases and investment, while device upgrade cycles and growing software adoption strengthen the longer-term outlook.

Among its peers, Honeywell International Inc. (HON - Free Report) and Avery Dennison Corporation (AVY - Free Report) shares have declined 55.5% and 2.6%, respectively, over the same time frame.

ZBRA’s 6-month Price Performance Image Source: Zacks Investment Research

Technical indicators for ZBRA show bullish momentum. The ZBRA stock has been trading above its 50-day simple moving average (SMA) since June 22, 2026. It is also currently trading above its 200-day SMA, suggesting a long-term uptrend. The 50-day SMA is also reading higher than the 200-day SMA, following a golden crossover on July 13, 2026, indicating a bullish trend.   

ZBRA Trades Above 50-Day SMA Image Source: Zacks Investment Research

Let’s take a look at ZBRA’s fundamentals to analyze the stock better.

ZBRA Rides on Business and Demand StrengthZebra Technologies is witnessing growth across the healthcare, manufacturing and retail & e-commerce end markets. Higher sales of mobile computing solutions are driving the company’s Connected Frontline segment. Revenues from the segment increased 25.9% (up 7.5% organically) year over year in the second quarter of 2026.

Solid demand for printing solutions, machine vision, data capture and RFID products is boosting the Asset Visibility & Automation segment’s performance. In the second quarter of 2026, the segment’s sales increased 13.5% (up 11.4% on an organic basis) on a year-over-year basis.

Zebra Technologies has been advancing digital capabilities, optimizing the supply chain, expanding its data analytics capability and focusing on marketing activities to better engage with customers. Driven by these initiatives and solid demand for its products, the company expects third-quarter 2026 net sales to increase in the band of 17-20% from the prior-year level. The company expects its 2026 revenues to grow 14-16% from the year-ago level.

Accretive Acquisitions Broaden the Addressable MarketZebra Technologies has steadily strengthened its business through acquisitions. In the second quarter of 2026, acquisitions and dispositions contributed 8.7 percentage points to total sales growth. In September 2025, Zebra Technologies completed the acquisition of Elo Touch Solutions, Inc. (Elo). The inclusion of Elo’s expertise in consumer-facing workflow, augmented by its suite of kiosks, edge computing, payment and touchscreen solutions, expands its addressable market by about $8 billion. The transaction expanded Zebra Technologies' reach across retail, healthcare, industrial and hospitality markets. In the second quarter of 2026, Elo delivered growth above management’s expectations, while joint selling efforts expanded the commercial pipeline and generated early customer wins.

In February 2025, Zebra Technologies acquired Photoneo, a market leader in the 3D machine vision solutions industry. The buyout enabled the company to combine Photoneo’s 3D machine vision solutions with its advanced sensors, vendor-agnostic software and AI-based image processing capabilities. This acquisition enhanced Zebra Technologies' portfolio of 3D machine vision solutions and addresses several challenges in high-value applications.

Cash Generation Backs ZBRA’s Shareholder-Friendly ActionsZBRA generated $361 million of free cash flow in the first six months of 2026, up 25.3% year over year. The company now expects full-year 2026 free cash flow of at least $1 billion, up from its prior expectation of at least $900 million. This cash generation supports continued investment, debt flexibility and shareholder returns.

Zebra Technologies has continued rewarding its shareholders. The company repurchased shares worth $568 million in the first six months of 2026. In February 2026, the company’s board of directors approved an additional share repurchase authorization of up to $1 billion. ZBRA expects to repurchase another $150 million of shares in the second half of 2026, bringing total full-year repurchases to roughly $700 million.

What ZBRA’s Earnings Estimates IndicateThe Zacks Consensus Estimate for ZBRA’s 2026 earnings has been stable over the past 60 days.  The consensus estimate for third-quarter 2026 earnings has also remained unchanged over the same time frame.

The Zacks Consensus Estimate for 2026 earnings is currently pegged at $21.14, suggesting year-over-year growth of 33.5%. Earnings are expected to register roughly 26.3% growth in the third quarter.

Image Source: Zacks Investment Research

A Look at ZBRA’s ValuationZBRA has a forward 12-month price-to-earnings ratio of 20.22X, in line with the industry average. It is trading at a discount to Honeywell and at a premium to Avery Dennison. Zebra Technologies has a Value Score of C, while Honeywell and Avery Dennison have a Value Score of B each.

ZBRA’s P/E F12M Vs. Industry, HON and AVY Image Source: Zacks Investment Research

Final Thoughts: Buy ZBRA SharesZebra Technologies remains well-positioned for growth, supported by broad demand for mobile computing, printing, machine vision and RFID across key end markets. Acquisitions such as Elo Touch and Photoneo are expanding its addressable market and strengthening automation and AI capabilities. Strong free cash flow enables investments and substantial share repurchases, while bullish technical momentum and healthy earnings growth expectations reinforce the outlook. With a Zacks Rank #2 (Buy), ZBRA remains an attractive buy for investors seeking continued growth and long-term upside.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

, /PRNewswire/ -- UWM Holdings Corporation (NYSE: UWMC) faces a securities class action lawsuit after the price of their shares cratered 34% on August 6, 2026 in response to revelations that the company suffered over a $603 million hedge loss associated with its failed bid to acquire Two Harbors Investment Corp. and, as a result, agreed to a plan to massively dilute existing shareholders.

Hagens Berman is investigating the alleged claims and encourages UWM investors who suffered substantial losses to submit your losses now.

Key Details

Class Period: Mar. 9, 2026 – Aug. 5, 2026
Lead Plaintiff Deadline: Oct. 13, 2026
Visit: www.hbsslaw.com/uwmc
Contact the Firm Now: [email protected]
                                         844-916-0895

UWM Holdings Corporation ($UWMC) Securities Class Action:

The suit centers on UWM's disclosures about its hedging strategy in connection with its attempt to acquire Two Harbors.

On December 17, 2025, mortgage lender UWM announced that it and mortgage servicing rights ("MSR") company Two Harbors entered into a merger agreement pursuant to which UWM would acquire Two Harbors for about $1.3 billion in UWM stock. Two Harbors was free to receive proposals superior to UWM's.

In connection with the proposed acquisition, UWM entered into significant hedging transactions against Two Harbors' MSR portfolio whose value typically and rapidly changes based on interest rates and homeowner refinancing speeds.

The complaint alleges that UWM did not disclose that it over-hedged in connection with its attempt to take over Two Harbors. The danger to this is that if an acquisition falls through the massive hedge left behind can turn into a speculative gamble.

Over four months ago, on March 27, 2026, Two Harbors announced that it entered a definitive merger agreement with CrossCountry Mortgage in a cash transaction and that it terminated its previous deal with UWM and would pay UWM the termination fee.

Although UWM had disclosed certain information about having hedged the transaction before March 27, investors did not learn the truth of the company's exposure until August 6, 2026. That day UWM reported three important things.

First, the company reported a massive $451 million net loss and roughly a $603 million hedging loss. Management revealed, apparently for the first time, that "we were over-hedged" and "obviously, the Two Harbors transaction went away."

Second, UWM disclosed that its total equity sequentially plunged by about $615 million, or a whopping 38%.

On top of that and third, UWM told shareholders in essence that, as a result of the foregoing, it entered into a massively dilutive recapitalization plan.

The market swiftly reacted, sending the price of UWM shares sharply lower that day. Between December 17, 2025, the day of the Two Harbors acquisition announcement, and August 6, 2026, the price Of UWM shares has declined by about $3.65 or 75%.

Hagens Berman's Investigation

"We're focused on UWM's explanations for why it refrained from unwinding its hedges months ago and why management seemingly went virtually silent on the naked hedging risks until recently," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.

If you invested in UWM and have substantial losses, or have knowledge that will assist the firm's investigation, submit your losses now »

Whistleblowers: Persons with non-public information regarding UWM should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

SOURCE Hagens Berman Sobol Shapiro LLP

Key Takeaways Generac's C&I revenues rose 29% to $556 million in Q2 2026, with data center sales exceeding $100 million. Generac's strong data center backlog and $2.4 billion Amazon deal strengthen its growth outlook.Excluding tariff refunds, GNRC expects 2026 gross margin near the low end of its 38.5-39.5% range.
Generac Holdings (GNRC - Free Report) is benefiting from strong momentum in its Commercial & Industrial (C&I) segment, especially as data center operators expand artificial intelligence (AI) infrastructure.

While the company’s growing exposure to data centers and multiyear hyperscale agreements improves revenue visibility, rising contributions from lower-margin C&I products challenge profitability.

Data Center Growth Boosts Generac's Revenue MixC&I revenues totaled $556 million in the second quarter of 2026, up 29% year over year, driven by data center demand, mobile product strength and international growth. Data center product sales contributed more than $100 million in the second quarter, while orders from domestic industrial distributors reached a record high, buoyed by demand across traditional C&I markets.

On the last earnings call, management said that C&I segment net sales are expected to increase in the low 30% range in 2026, up from the prior mid-to-high 20% outlook.

Management expects data centers to remain a significant long-term growth opportunity amid accelerating infrastructure investments and AI adoption.

On the last earnings call, Generac noted that the data center backlog reached $1.6 billion as of July 2026, including roughly $1 billion of new orders received in the prior 90 days, while excluding expected orders from the second hyperscale agreement. Management also raised its 2026 data center revenue expectation to roughly $450 million, underscoring the rapid scaling of this business. Since then, Generac has finalized a long-term supply agreement with Amazon, with initial backup-generator deliveries expected to total $2.4 billion across 2027 and 2028.

Continued demand from data centers, mobile equipment and C&I energy storage systems supports a broader growth profile beyond a single end market.

The Profitability TroublesExcluding tariff refunds, management expects 2026 gross margin near the low end of the prior 38.5% to 39.5% range due to higher C&I mix. C&I products generally carry lower margins than residential offerings.

In the second quarter of 2026, consolidated gross margin reached 44.5% from 39.3%. Tariff refunds added roughly 6% to gross margin growth. Also, favorable pricing partly offset unfavorable sales mix and higher input costs.

Despite these pressures, management maintained its 2026 adjusted EBITDA margin guidance of 18.5-19.5%, excluding tariff refunds. Significant operating leverage is expected to cushion EBITDA margins in the fourth quarter.

Margin Profile for CompetitorsCummins (CMI - Free Report) is also rapidly expanding its data center footprint. The company is developing a 130-liter natural gas genset for prime power and supplying Circe Energy with QSK60 and HSK78 generators with microgrid technology for a prime power solution supporting a high-performance computing data center in Texas. In August, Cummins was selected to supply battery energy storage systems (“BESS”) for a large U.S. data center project, which would represent its largest BESS deployment to date.

Second-quarter 2026 Power Systems revenues rose 19% to $2.3 billion and the segment's EBITDA margin expanded to 24.5% from 22.8%, driven primarily by higher global power generation demand. Cummins expects Power Systems revenues to grow 14-19% in 2026, with EBITDA margins of 25-25.75%.

Caterpillar (CAT - Free Report) is also expanding aggressively in data-center power, increasing competitive pressure. Second-quarter 2026 Power & Energy revenues increased 17% year over year to $8.2 billion, while segment operating margin expanded 250 basis points to 24.6%, aided by higher volumes and favorable pricing. Caterpillar expects Power & Energy margins to improve year over year in the third quarter, supported by higher sales volumes and favorable pricing, partially offset by higher manufacturing costs and capacity expansion expenses.

With shipments expected to commence in the fourth quarter, Caterpillar is adding capacity, including restarting a 10-MW medium-speed gas reciprocating platform with about 1.5 GW of planned capacity.

GNRC Price Performance, Valuation and EstimatesGNRC’s shares are up 27.1% in the past month while the Manufacturing-General Industrial sector has inched up 2.2%.

Image Source: Zacks Investment Research

Generac is trading at a forward 12-month price/earnings ratio of 19.07X, lower than the sector’s multiple of 20.25X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for GNRC earnings for 2026 has seen a marginal downward revision over the past 60 days.

Image Source: Zacks Investment Research

GNRC currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key Takeaways Cabot's battery materials expansion and improved earnings outlook strengthen its long-term growth prospects.CBT targets $40 million in battery materials EBITDA in fiscal 2026, backed by rising global battery demand.Cabot generated $278 million in nine-month operating cash flow and targets $30 million in cost savings. Cabot Corporation (CBT - Free Report) is benefiting from capital-efficient investments in capacity expansion to match battery materials demand growth. Upbeat earnings outlook also boosts investors’ confidence. Disciplined cost control and continuous cash generation also position CBT for long-term growth.

We are positive about CBT’s prospects and believe that the time is right for you to add the stock to the portfolio, as it looks promising and is poised to carry the momentum ahead.

Let's see what makes CBT stock an attractive investment option at the moment.

An OutperformerCBT’s shares have gained 7.7% compared with the industry’s rise of 0.2% in the past year.

Image Source: Zacks Investment Research

CBT’s Positive Earnings Surprise HistoryCBT has outpaced the Zacks Consensus Estimate in three of the trailing four quarters. In this time frame, it has delivered an earnings surprise of roughly 4.6%, on average.

CBT’s Superior Return on Equity (ROE)ROE is a measure of a company’s efficiency in utilizing shareholders’ funds. ROE for the trailing 12-months for CBT is 20.29%, above the industry’s level of 7.62%.

Image Source: Zacks Investment Research

Upbeat OutlookFor fiscal 2026, Cabot revised its adjusted earnings guidance to $6.15-$6.45 per share from the previous range of $6-$6.5. The company expects its full-year fiscal 2026 operating tax rate to be in the range of 28-30%. Cabot also reaffirmed its expectation of approximately $40 million of EBITDA from its battery materials product line for fiscal  2026. The company is expanding global conductive additive capacity through targeted investments in the United States and China to support expected growth in global battery demand and broaden its participation with leading battery manufacturers.

Battery Materials Growth and Capacity ExpansionCabot’s Battery Materials business is supported by rising demand for electric vehicles and battery energy storage systems. The company expects global battery demand to more than double by 2030 and reaffirmed its fiscal 2026 EBITDA target of approximately $40 million for Battery Materials. Acquisitions in China, including NSCC Carbon, carbon nanotube assets and Shenzhen Sanshun Nano New Materials, are strengthening its position.

Additionally, Cabot’s has also planned $125 million U.S. expansion across two existing manufacturing sites. It is expected to bring new capacity online by 2028. Its capital efficient capacity additions will align with rising customer demand, positioning the company for long-term battery market growth.

Strong Cash Generation and Cost Cutting Support ReturnsRobust cash generation and disciplined cost management are strengthening its financial flexibility and ability to support shareholder returns. The company generated $75 million in operating cash flow in the third quarter of fiscal 2026 and $278 million in the first nine months of the fiscal year. Its fiscal 2026 cost plan targets approximately $30 million in savings, supported by restructuring initiatives, including the cessation of production at Campana and planned closures of units at Botlek in fiscal 2027. These measures are expected to support profitability, while investments in sustainable manufacturing, including circular reinforcing carbons produced at its Ville Platte, LA, facility, provide additional opportunities.

CBT’s Zacks Rank & Other Key PicksCBT currently sports a Zacks Rank #2 (Buy).

Other top-ranked stocks in the Basic Materials space are Aperam S.A. (APEMY - Free Report) , Reliance, Inc. (RS - Free Report) and Axalta Coating Systems Ltd. (AXTA - Free Report) .

APEMY sports a Zacks Rank #1 (Strong Buy) while RS and AXTA carry a Zacks Rank #2 each. You can see the complete list of today’s Zacks #1 Rank stocks here

The Zacks Consensus Estimate for APEMY’s current fiscal-year earnings is pinned at $3.30 per share. APEMY’sshares have gained 15% over the past year.

The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $23.23 per share, indicating a 62.9% year-over-year increase. RS’shares have gained 46.1% over the past year.

The Zacks Consensus Estimate for AXTA’s fiscal 2026 earnings is pegged at $2.63 per share, indicating a rise of 5.62% year over year. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, with an average surprise of 6.45%.

Axsome Therapeutics (AXSM -0.47%) entered 2026 with Auvelity already generating more than half a billion dollars in annual sales for major depressive disorder. Now the drug is expanding into a second potentially massive market: agitation associated with Alzheimer's disease.

In April, the FDA approved Auvelity for agitation associated with dementia due to Alzheimer's disease, making it the first approved treatment for the condition that isn't an antipsychotic. Axsome launched it for the new indication in June. And the early numbers look good.

Auvelity generated $180.3 million in second-quarter sales, up 51% year over year. During the first eight weeks following the Alzheimer's launch, new patient starts among people 65 and older jumped 126% compared with the same period in the previous quarter.

Auvelity is becoming a much bigger drug
Auvelity was originally approved in 2022 for major depressive disorder. By 2025, sales reached $507.1 million. Now, Alzheimer's agitation treatment dramatically expands that opportunity.

Image source: Getty Images.

To clarify, agitation can include excessive movement, restlessness, verbal aggression, and physical aggression. It's also one of the most difficult symptoms for caregivers to manage.

Axsome now believes Auvelity can eventually generate at least $8 billion in annual peak sales, with roughly half coming from depression and half from Alzheimer's agitation. To be clear, that's a company estimate rather than a forecast, and management hasn't said when it expects Auvelity to reach that level. Still, the trajectory is hard to ignore.

The drugmaker expanded the Auvelity sales force from roughly 300 representatives to more than 600 to reach psychiatrists, neurologists, geriatric specialists, and primary-care doctors. Insurance coverage has also reached approximately 89% of covered lives. . If the Alzheimer's launch continues to gain traction, Auvelity could potentially generate several billion dollars annually by the end of the decade.

This isn't just about Auvelity
Axsome already has two other commercial products. There's Sunosi, which is used to treat excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. That generated $35.8 million in Q2 revenue. Then there's Symbravo, Axsome's migraine treatment. This one is much newer and only generated $2.3 million in Q2 sales, but underlying demand is growing quickly, with prescriptions rising 30% from the previous quarter to approximately 23,500 in Q2. Axsome believes the drug could eventually generate $500 million to $1 billion in annual peak sales.

Premium Feature

Moneyball Superscore

77/100

Today's Change

(

-0.47

%) $

-0.80

Current Price

$

167.56

There's also the pipeline, which includes AXS-12 and AXS-14. AXS-12 is being developed for narcolepsy, with an FDA decision currently scheduled for May 1, 2027. AXS-14 is being developed for fibromyalgia and has already produced positive Phase 3 results. Axsome is also studying solriamfetol, a "wakefulness-promoting" medication in additional conditions, including ADHD, depression, and binge eating disorder.

Overall, management believes its pipeline could support an average of one new FDA drug application filing per year through 2030. Of course, not all of those programs will necessarily succeed. But Axsome no longer needs every pipeline candidate to work, for the company to grow substantially.

What could Axsome look like in 2030?
The biggest risk is execution. Axsome is spending aggressively to commercialize its drugs. Selling, general, and administrative expenses totaled $208.1 million in Q2, yet the company posted a $51.3 million net loss despite generating $218.4 million in product revenue.

That spending makes sense if Auvelity continues scaling rapidly. It becomes more problematic if the Alzheimer's launch disappoints. But if it plays out as management expects, Axsome could have a multibillion-dollar flagship drug supported by several additional commercial products by 2030.

Now, Auvelity doesn't need to reach $8 billion by 2030 for that scenario to work. If depression treatment sales keep climbing, Alzheimer's agitation becomes another major market, and even a few pipeline programs reach commercialization, Axsome could graduate from a successful biotech to a sizable neuroscience pharmaceutical company.

Fifth Third Bancorp (FITB - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on October 19, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly earnings of $1.09 per share in its upcoming report, which represents a year-over-year change of +17.2%.

Revenues are expected to be $3.34 billion, up 45.2% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.73% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Fifth Third Bancorp?For Fifth Third Bancorp, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.89%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination indicates that Fifth Third Bancorp will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Fifth Third Bancorp would post earnings of $0.98 per share when it actually produced earnings of $1.02, delivering a surprise of +4.08%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Fifth Third Bancorp appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerM&T Bank Corporation (MTB - Free Report) , another stock in the Zacks Banks - Major Regional industry, is expected to report earnings per share of $4.98 for the quarter ended September 2026. This estimate points to a year-over-year change of +2.3%. Revenues for the quarter are expected to be $2.54 billion, up 1% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for M&T Bank has been revised 1.2% down to the current level. Nevertheless, the company now has an Earnings ESP of +0.73%, reflecting a higher Most Accurate Estimate.

When combined with a Zacks Rank of #3 (Hold), this Earnings ESP indicates that M&T Bank will most likely beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Lumentum's order book is booked solid through early 2029, yet its stock is leading the entire AI optics sector lower today. When the most visible demand story in the group takes the hardest hit, something worth watching is happening inside…

Lumentum (NASDAQ:LITE | LITE Price Prediction) stock is down 10% to $996.95 in midday trading, leading a sharp retreat across artificial intelligence (AI) optical connectivity names. This drop stands out because Lumentum’s production capacity is spoken for through early 2029, and that combination of the deepest decline with the longest order visibility frames the selloff.

For an optics/photonics sector check, the Roundhill Photonics & Optics ETF (CBOE:LYTE) is down 7% to $23.11. The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is essentially flat at $778.75, so the damage is staying inside one corner of the market. A 7% slide in the optical fund against a flat benchmark marks this as a group-specific selloff.

Meanwhile, Applied Optoelectronics (NASDAQ:AAOI) stock is down 7% to $101.50, falling less than Lumentum stock has. Additionally, Coherent (NYSE:COHR) stock is down 7% to $289.68, tracking Applied Optoelectronics stock almost step for step. All three had ranked among the strongest AI infrastructure winners heading into the decline.

A Sold-Out Order Book Meets Group Selling None of the three companies has issued a new press release ahead of the decline. That leaves selling spread across the whole optical group. These are the same AI expansion suppliers we profiled in a free report on seven non-chipmakers powering the boom, with the three stocks and the fund dropping in together. The slide in Lumentum stock is the steepest of the group, which makes it the clearest gauge of how hard the selling is landing.

On October 9, Lumentum’s chief executive said the company’s AI optical components are booked through early 2029, and the optical names rose that day. Coverage framed that rally around Lumentum being unable to keep up with AI demand (Barron’s). Those remarks are three days old and aren’t the cause of the current decline.

What the Peer Group Says About Lumentum As of its August 6 fact sheet, the Roundhill fund held Lumentum at 15.4% and Coherent at 15.2% of net assets, with Applied Optoelectronics at 2.1%. The fund and three stocks fell within a narrow range. The pattern points to group-level selling that hits every name regardless of its individual story.

Lumentum’s risk is that a stock up 170% year to date gives back the most when the group turns. At a forward P/E ratio of 43x, Lumentum stock carries little margin, and a full order book doesn’t protect a multiple. Lumentum shares also sit well above the 200-day moving average of $764.19, a sign of how far the run extended.

A bullish reading starts from an unchanged demand picture since October 9, because a sold-out order book signals demand running ahead of supply. Lumentum hosted its August 11 earnings call. On the call, Lumentum’s chief executive stated, “Pumped laser shipments surged more than 80% year over year, and we will remain effectively sold out for the foreseeable future, despite our rapid capacity expansion.” Management also said Lumentum reached its target operating model more than a quarter ahead of schedule.

What to Watch Next The key question for Lumentum is whether its booked capacity turns into reported revenue on schedule. Lumentum guided for current-quarter revenue of $1.225 billion to $1.275 billion after posting $1.006 billion last quarter, up 109.3% year over year. Hitting that range could show the order book translating into results on time.

The 10% drop in Lumentum stock shows how fast the optical names can reverse together, even with demand intact. Investors should hold small enough stakes that a group-wide decline stays within their risk tolerance.

Contact [email protected] for any questions or corrections.

DataMeds AI, Inc. (NASDAQ:MEDS) shares are up on Monday as traders react to Medicaid coverage policy news tied to the company’s Helomics business and its ChemoFx assay.

DataMeds AI said Humana Inc. (NYSE:HUM) has added ChemoFx to its Medicaid Pharmacogenomics Testing coverage policy, expanding payer coverage for the assay in gynecologic cancers.

Upticks like this can happen when investors see a clearer reimbursement path, since coverage decisions can directly affect test adoption and revenue visibility for diagnostics products.

Cost-Effectiveness & Clinical Utility DataHumana members may be eligible under the Plan for ChemoFx Assay (CPT Codes 81535 and 81536) to determine how cancer cells may respond to chemotherapeutic agents for an individual diagnosed with gynecologic cancer (e.g., cervical, endometrial, fallopian tube, gynecologic sarcoma, ovarian, primary peritoneal).

Read Next

ChemoFx presented an incremental cost-effectiveness ratio (ICER) of $6,206 per life-year saved (LYS) for patients with recurrent EOC who are treated according to ChemoFx results (compared to similar patients whose treatment decisions were made without ChemoFx).

Cost-effectiveness was further demonstrated in both platinum-sensitive and platinum-resistant populations treated with assay-sensitive therapies with ICERs of $2,773 per LYS and $2,736 per LYS, respectively.

The mean costs of chemotherapy treatment for recurrent ovarian cancer were estimated to be $48,758 for empirically treated patients, $33,187 for assay-assisted patients, and $23,986 for assay-adherent patients.

Regulatory Status & LimitationsAccording to this study, assay-assisted treatment decisions in recurrent ovarian cancer may result in reduced costs compared to empiric treatment selections.

These results may not reflect current treatment patterns or costs.

The ChemoFx Assay is a laboratory-developed test and has not been cleared or approved by the U.S. Food and Drug Administration.

MEDS Stock Price Activity: DataMEDS AI shares are trading higher by 7.60% at $3.19 at the time of publication on Monday, according to Benzinga Pro data.

Image via Shutterstock

Read Next

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Enovix Corporation (NASDAQ:ENVX) stock is trading higher by more than 2% on Monday as the manufacturer of advanced lithium-ion batteries reported strong preliminary third-quarter 2026 results.

The company reported revenue of $11 million, up 38% from the previous year, beating its guidance of $9 million to $10 million.

• Enovix stock is gaining positive traction. What’s driving ENVX shares up?

The sales growth represented the company’s sixth consecutive quarter of year-over-year revenue growth.

Non-GAAP operating loss reached $29.2 million compared to guidance of $29 to $32 million in operating loss. Non-GAAP loss per share was 14 cents compared to guidance of loss per share of 13 cents to 17 cents.

Enovix held $512 million in cash and cash equivalents as of Oct. 4.

Drone and Defense Demand Fuels GrowthDrone and defense customers accounted for nearly 70% of quarterly revenue.

The company’s combined drone, defense and industrial pipeline increased 18% to $216 million, while its drone-specific pipeline surged 48% to nearly $150 million.

To capitalize on increasing demand for non-Chinese batteries among the U.S. and allied defense programs, Enovix is investing $19 million to double production capacity at its South Korean manufacturing facility.

Interim CEO Ryan Benton highlighted accelerating commercial momentum, with purchase orders received early in the fourth quarter already surpassing total third-quarter revenue.

Leadership ChangesThe company realigned its leadership team to scale its production efforts and to support customers amid the rapidly rising order mandates and demand for multiple sub-markets, including aerial, subsea and maritime drone programs.

The company promoted Steve Bakos to chief revenue officer and general manager, while James Wilcox was named vice president of Corporate Strategy.

Also, hired Dan Wark to lead its new global supply chain organization focused on consolidating production planning, procurement and sourcing.

Analyst OutlookThe stock carries a Buy rating with an average price forecast of $12.94 (high: $25; low: $5.50) across 11 analysts.

Recent analyst moves include:

StoneX: Buy (Lowers target to $10 on Oct. 9)
William Blair: Downgraded to Market Perform on Aug. 17
Canaccord Genuity: Buy (Lowers target to $10 on Aug. 14)
ENVX Price Action: Enovix shares were up 2.53% at $2.53 at the time of publication on Monday. The stock is trading near its 52-week low of $2.40, according to Benzinga Pro data.

Image via Shutterstock

Read Next

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Key Takeaways CAG's Foodservice operating profit rose 11.4% in Q1, while adjusted margin expanded 83 basis points.Foodservice organic sales grew 3.3%, marking five straight quarters of growth, with volumes rising 2.5%.Productivity gains offset inflation, though accelerated customer orders supported volume growth.
Conagra Brands, Inc. (CAG - Free Report) delivered encouraging growth in the Foodservice segment in the first quarter of fiscal 2027, supported by higher organic sales, improved volumes and productivity gains. The business recorded growth in both operating profit and operating margin despite continued inflationary pressures. Stronger sales performance and cost efficiencies helped offset higher input costs, highlighting the segment's ability to deliver improved profitability in a challenging operating environment.

Foodservice net sales increased 3.2% year over year to $272.9 million in the fiscal first quarter, while organic net sales advanced 3.3%. The segment marked the fifth consecutive quarter of organic sales growth, reflecting sustained positive sales trends. Volume increased 2.5%, while favorable price/mix contributed 0.8 percentage points to organic sales growth. However, approximately 150 basis points of volume growth came from the accelerated timing of specific customer orders, which occurred in the third quarter of the previous fiscal year.

This improvement in sales contributed to stronger profitability. Foodservice operating profit and adjusted operating profit increased 11.4% year over year to $30.9 million. Adjusted operating margin expanded 83 basis points to 11.3%. Higher organic net sales and productivity improvements more than offset the negative impact of cost-of-goods-sold inflation, allowing the segment to deliver growth in both profit and margin in the fiscal quarter.

Conagra Brands' Foodservice segment continues to benefit from organic sales growth and productivity improvements despite inflationary pressures. However, the contribution from accelerated customer orders to quarterly volume growth remains an important consideration. Going forward, sustaining profit momentum will depend on continued sales growth and productivity gains offsetting higher costs. The latest quarterly performance demonstrates positive progress in Foodservice profitability, with sales growth and cost efficiencies providing support.

Conagra Brands’ Zacks Rank & Share Price PerformanceShares of this Zacks Rank #3 (Hold) company have fallen 8.8% over the past month, underperforming the industry and the broader Consumer Staples sector, which declined 5% and 2.5%, respectively. CAG also underperformed the S&P 500 index, which gained 3.1% over the same period.

CAG Stock's Past Month Performance
Image Source: Zacks Investment Research

Is CAG a Value Play Stock?Conagra Brands currently trades at a forward 12-month P/E ratio of 9.2, which is down from the industry average of 13.79 and the sector average of 16.82. This valuation places the stock at a modest discount relative to comparable peers and the sector overall.

CAG P/E Ratio (Forward 12 Months)
Image Source: Zacks Investment Research

Stocks to ConsiderThe Chefs' Warehouse, Inc. (CHEF - Free Report) distributes specialty food and center-of-the-plate products in the United States, the Middle East and Canada. At present, CHEF flaunts a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The consensus estimate for Chefs' Warehouse’s current fiscal-year sales and earnings implies growth of 10.8% and 33.7%, respectively, from the year-ago reported figures. Chefs' Warehouse delivered a trailing four-quarter earnings surprise of 30.4%, on average.

Mama's Creations, Inc. (MAMA - Free Report) manufactures and markets fresh deli-prepared foods in the United States. At present, MAMA holds a Zacks Rank of 2. Mama's Creations delivered a trailing four-quarter earnings surprise of 121.7%, on average.

The consensus estimate for Mama's Creations’ current fiscal-year sales and earnings implies growth of 30.3% and 66.7%, respectively, from the year-ago figures.

Utz Brands (UTZ - Free Report) engages in the manufacture, marketing and distribution of snack foods in the United States. It presently carries a Zacks Rank of 2. UTZ delivered a trailing four-quarter earnings surprise of 1.8%, on average.

The Zacks Consensus Estimate for Utz Brands’ current financial-year sales indicates growth of 3.7% from the year-ago numbers.

The upcoming report from Simmons First National (SFNC - Free Report) is expected to reveal quarterly earnings of $0.53 per share, indicating an increase of 15.2% compared to the year-ago period. Analysts forecast revenues of $255.21 million, representing an increase of 10% year over year.

Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.2% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.

Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.

While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.

Given this perspective, it's time to examine the average forecasts of specific Simmons First National metrics that are routinely monitored and predicted by Wall Street analysts.

The consensus estimate for 'Net Interest Margin' stands at 3.9%. The estimate compares to the year-ago value of 3.5%.

Based on the collective assessment of analysts, 'Total interest earning assets (FTE) - Average Balance' should arrive at $21.46 billion. Compared to the present estimate, the company reported $21.56 billion in the same quarter last year.

Analysts expect 'Total nonperforming loans' to come in at $164.30 million. The estimate is in contrast to the year-ago figure of $153.94 million.

The collective assessment of analysts points to an estimated 'Total nonperforming assets' of $176.51 million. The estimate is in contrast to the year-ago figure of $160.72 million.

Analysts forecast 'Total Non-Interest Income' to reach $46.97 million. The estimate compares to the year-ago value of $45.31 million.

It is projected by analysts that the 'Net Interest Income - FTE' will reach $208.21 million. The estimate is in contrast to the year-ago figure of $190.47 million.

According to the collective judgment of analysts, 'Net Interest Income' should come in at $204.41 million. Compared to the present estimate, the company reported $186.66 million in the same quarter last year.

Analysts' assessment points toward 'Wealth management fees' reaching $10.34 million. The estimate is in contrast to the year-ago figure of $9.97 million.

The consensus among analysts is that 'Service charges on deposit accounts' will reach $12.48 million. The estimate is in contrast to the year-ago figure of $13.05 million.

The average prediction of analysts places 'Debit and credit card fees' at $9.01 million. The estimate is in contrast to the year-ago figure of $8.48 million.

View all Key Company Metrics for Simmons First National here>>>

Over the past month, shares of Simmons First National have returned -4.4% versus the Zacks S&P 500 composite's +2.4% change. Currently, SFNC carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

SummarySoFi Technologies, Inc. remains a Buy, with a focus on achieving its ambitious 2026 profit target despite margin pressures.SOFI's incremental margin must reach 52–62% in H2 to hit $1.6B adjusted EBITDA, but strong revenue growth could ease this requirement.SoFiUSD and SoFi Plus offer optionality and cross-sell potential, though near-term financial impact from SoFiUSD is limited.Rising deposit costs pose a risk, but deposit stickiness and product engagement support confidence in SOFI's growth trajectory. Joe Hendrickson/iStock Editorial via Getty Images

SoFi Technologies, Inc. (SOFI) reports third-quarter results on the morning of October 27. The stock also closed at $15.80 on Oct. 9, about 12%, below where it traded when I

5.09K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

-

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NasdaqGS: DNUT).

On October 26, 2022, the Company commenced a small-scale test to offer doughnuts at McDonald's Corporation ("McDonald's") restaurants in Louisville, Kentucky, and the surrounding area. On March 26, 2024, the Company and McDonald's announced that they would expand the partnership nationwide beginning in the second half of 2024. On February 25, 2025, the Company reassured investors regarding the growth opportunities of the partnership and the potential profitability of the U.S. national rollout, and "remain[ed] on track to reach about 6,000 restaurants by year end."

However, on May 8, 2025, the Company disclosed that it was pausing the McDonald's rollout—the centerpiece of its U.S. growth strategy. The Company announced that it was "reassessing the deployment schedule together with McDonald's while it works to achieve a profitable business model for all parties and does not expect to launch in any additional restaurants in the second quarter of 2025." The Company further disclosed that, as of March 30, 2025, Krispy Kreme doughnuts remained available in just over 2,400 McDonald's restaurants, effectively unchanged from the total reached on February 25, 2025, revealing that the expansion had stalled almost immediately after it assured investors that it was on track.

Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period in violation of federal securities laws, which remains ongoing.

KSF’s investigation is focusing on whether Krispy Kreme’s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of Krispy Kreme shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-538-3606 or email KSF Managing Partner Lewis Kahn ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-dnut/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

More News From Kahn Swick & Foti, LLC

Back to Newsroom

Electric vertical takeoff and landing aircraft (eVTOLs) could change how we think about transportation. Thanks to modern technology, these aircraft can take off like helicopters and transition to flight like airplanes.

While eVTOLs could change how we get around cities, they are also highly appealing for military purposes. Their electric motors are 1,000 times quieter than helicopters, making them harder to detect during missions. They also require less maintenance and are agile enough to perform rescue and reconnaissance missions.

Archer Aviation (ACHR -5.44%) is an eVTOL developer with a growing defense business alongside its commercial ambitions. Here's why Archer Aviation is so well-positioned to capture defense dollars flowing into eVTOLs.

Image source: Archer Aviation.

Archer is working with the U.S. Air Force and winning defense contracts
eVTOLs offer a distinct advantage for military use, including lower acoustic and thermal signatures and the ability to maneuver in tight spaces. The United States Air Force created the AFWERX Agility Prime program to accelerate eVTOL technology. This program grants military airworthiness evaluations and access to military test ranges.

Archer Aviation has positioned itself as a key player in this program. Through its AFWERX partnership, Archer secured defense contracts worth up to $142 million to evaluate its Midnight aircraft for military use cases. Under this program, the Air Force took delivery of Midnight and validated its flight performance, maintenance turnaround time, and tactical use on military ranges.

Premium Feature

Moneyball Superscore

59/100

Today's Change

(

-5.44

%) $

-0.27

Current Price

$

4.69

This comes as Archer scales up its Archer Defense segment. In 2024, Archer teamed up with Anduril Industries, a next-generation defense prime specializing in uncrewed autonomous hardware and command-and-control software.

On July 20, Anduril and Archer Aviation revealed their jointly developed autonomous VTOL aircraft platform. As part of the reveal, Anduril showcased Thunder, an autonomous attack aircraft built using technology from Archer's Midnight aircraft. Archer raised $430 million in equity following this announcement.

Archer Defense provides revenue while working toward a commercial launch
Archer continues to build on its defense business. On Aug. 10, Archer announced it would acquire aerospace assets from Boeing in an all-stock deal, giving Boeing roughly a 19.75% stake in Archer after closing.

As part of this deal, Archer will acquire military drone maker Insitu, eVTOL developer Wisk Aero, and airspace software company SkyGrid. Insitu will provide Archer with a company that is already operating and generating over $200 million in annual revenue.

Archer Aviation is seeking Federal Aviation Administration certification for its eVTOLs for commercial use and hopes to begin passenger flights in the next year or two. In the meantime, integrating defense into its business provides an alternative revenue and cash-flow source as it seeks certification and scales manufacturing.

New York, New York--(Newsfile Corp. - October 12, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS) on behalf of investors that purchased or otherwise acquired Doximity common stock between August 8, 2024 and May 13, 2026 (the "Class Period").

CLICK HERE TO JOIN THE CASE

If you are an investor in Doximity and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.

DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than November 16, 2026 for an opportunity to be lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.

The complaint alleges that throughout the Class Period, Doximity claimed that the Company's Newsfeed was its "biggest revenue driver." The truth - that Doximity overstated the impact that its Newsfeed would have on its revenue growth, and that the Company was losing market share to its competitors with more favorable pricing and engagement models - was allegedly revealed through a series of disclosures ending on May 13, 2026 when Doximity announced that it missed its already-reduced revenue guidance for the fiscal year ending March 31, 2026. Following this news, the price of Doximity stock declined by $5.38 per share, or 23%, on May 14, 2026.

WHY CONTACT KAPLAN FOX?

Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.

Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America-the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act-$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.

For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.

If you have any questions about this Notice, your rights, or your interests, please contact:

Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.

https://www.kaplanfox.com/case/doximity-nyse-docs-class-action-lawsuit-learn-more-now/

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/318521

Source: Kaplan Fox & Kilsheimer LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Key Takeaways Framo plans to expand its Rio facility as installed pumps in Brazil are projected to exceed 1,500 by 2028.The agreement covers inspections, maintenance and training for four types of critical pumping systems.Framo plans to expand its Rio facility as installed pumps in Brazil are projected to exceed 1,500 by 2028.
Petrobras (PBR - Free Report) has entered into a four-year agreement with Norwegian pump specialist Framo to service pumping equipment installed across approximately 30 floating production, storage and offloading (“FPSO”) vessels. The arrangement includes equipment inspections, maintenance work and training for systems used in seawater lifting, firefighting, crude oil handling and water injection. According to Framo, the deal is the largest service contract of its kind in the company's history.

This agreement gives Petrobras a long-term arrangement for maintaining essential equipment at its offshore facilities. This also reflects the importance of specialized engineering services as Brazil continues to develop its offshore oil and gas resources.

Petrobras Secures Maintenance Support for Offshore AssetsFPSOs help as offshore production facilities where hydrocarbons are processed, and crude oil is stored before shipment. Their equipment must perform reliably under demanding operating conditions, making the upkeep of critical pumping systems an important part of asset management.

Framo's tasks under the agreement cover four main categories of pumps. Seawater lift equipment supplies water for offshore operations, while firewater pumps serve emergency response requirements. Cargo pumps handle crude oil movements, and water injection systems help maintain pressure within producing reservoirs.

These systems have distinct functions, but their maintenance requirements can overlap in terms of inspection planning, technical expertise and workforce training. By placing the covered services under one agreement, Petrobras can coordinate these activities across its fleet instead of arranging each requirement independently.

A planned maintenance approach can help operators identify equipment defects and schedule corrective work before problems become more disruptive. Training is another component of the arrangement, supporting the skills needed to service specialized pumping equipment.

However, the agreement alone does not confirm that Petrobras will experience fewer production interruptions or lower maintenance expenses. Those outcomes will depend on the quality of execution and the performance of the equipment throughout the contract period.

Framo Builds Capacity for Brazil's Offshore MarketFramo expects the number of its pumps installed in Brazil to exceed 1,500 by 2028. The company attributes the anticipated expansion to additional FPSOs entering the market. This figure represents Framo's projection, rather than a confirmed future total.

To accommodate expected service demand, Framo is expanding its maintenance capabilities in Rio de Janeiro with a new facility at Galeão. The planned facility will be used for equipment inspections, maintenance and training. The announcement does not establish an opening date or confirm that the facility is already operating.

Framo has maintained a presence in Brazil since 1995 and operates as part of the Alfa Laval Group. Its experience in the market provides a base for supporting offshore customers as equipment requirements evolve.

The planned facility is relevant because offshore operators need technical support after equipment has been installed. Servicing specialized pumps requires appropriate expertise and coordination with operating schedules. Additional local capacity could make that support easier to access, although the resulting operational benefits have not been quantified.

For Framo, the agreement and facility expansion align with its plans to support a larger installed equipment base. For Petrobras, the arrangement establishes a service relationship with a supplier experienced in the Brazilian offshore market.

Assessing the Agreement's Significance for PetrobrasThe agreement establishes a dedicated service program for pumping equipment across Petrobras’ FPSO fleet. Planned inspections, maintenance and training are expected to improve service coordination and help identify equipment needs.

The financial implications, however, remain unclear. The announcement does not disclose the contract value, expected cost savings or any additional production anticipated from the agreement. There is therefore insufficient information to estimate its effect on Petrobras' revenue, earnings or cash flow.

Investors should also distinguish between a maintenance agreement and a direct production-growth initiative. This contract supports equipment servicing, but it does not announce new reserves, additional production capacity or a specific operating-cost target.

Its longer-term importance will depend on whether Petrobras can translate the maintenance program into measurable operating improvements. Relevant indicators would include equipment availability, maintenance efficiency and any subsequent disclosure of cost savings. Until further details are disclosed, the agreement should be viewed as an effort to strengthen offshore equipment support rather than a direct financial catalyst.

Overall, the deal provides Petrobras with a four-year framework for servicing critical pumping systems, while Framo prepares to support anticipated growth in Brazil. The arrangement strengthens the maintenance structure around Petrobras' offshore assets, although its direct financial contribution remains unestablished.

PBR's Zacks Rank & Key PicksCurrently, PBR carries a Zacks Rank #3 (Hold).

Investors interested in the energy sector might consider some better-ranked stocks, such as Marathon Petroleum (MPC - Free Report) , Delek US Holdings (DK - Free Report) and Oceaneering International (OII - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Marathon Petroleum is valued at $132.84 billion. The company is a leading U.S. independent refiner, marketer and transporter of petroleum products, with a strong refining footprint and an extensive midstream business. Marathon Petroleum benefits from its integrated operations, strategic refining assets and diversified earnings streams across the energy value chain.

Delek US Holdings is valued at $4.56 billion. It is a diversified downstream energy company engaged in petroleum refining, renewable fuels, asphalt production and logistics operations. Delek US Holdings operates multiple refineries in the United States and is committed to delivering safe, reliable energy while investing in cleaner energy initiatives.

Oceaneering International is valued at $4.46 billion. It is a global technology and engineering company. Oceaneering International provides subsea robotics, offshore services, engineered products and advanced solutions to the energy, defense, aerospace and other industries.  

, /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by D-Wave Quantum Inc. ("D-Wave") (NASDAQ: QBTS) on behalf of investors who purchased or acquired D-Wave securities and experienced significant financial losses.

D-Wave Reports Disappointing Financial Results

On August 6, 2026, D-Wave reported disappointing financial results for the second quarter of 2026 including, among other items, revenue of only $3.08 million, missing analyst expectations in the range of $4.03 million to $4.08 million. Then, on August 25, 2026, D-Wave issued a press release announcing the resignation of its CFO, effective September 2, 2026.

D-Wave's Stock Drops Over 9%

Following the August 6, 2026, news of D-Wave's poor financial results, the company's stock price fell over 9%, and fell again, over 9%, on August 26, 2026.

Investors who purchased D-Wave Quantum Inc. (NASDAQ: QBTS) securities and experienced losses may have legal rights under the federal securities laws.

CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS:    

If you purchased or acquired D-Wave Quantum Inc. securities and have lost money on your investment, please provide your information here:
https://www.ktmc.com/qbts-dwave-quantum-inc-investigation?utm_campaign=hc?utm_source=PR_Newswire&utm_medium=pressrelease&utm_campaign=qbts&mktm=PR 

There is no cost or obligation to speak with an attorney.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC):    

Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including being recognized in Chambers & Partners USA 2026 as a Band 1 Top Firm in Securities and Class Actions, Legal 500's Tier 1 Rankings for Securities and M&A Litigation, The National Law Journal's Plaintiff's Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group's Honor Roll of Most Feared Law Firms, The Legal Intelligencer's Class Action Firm of the Year, Lawdragon's Leading Plaintiff Financial Lawyers, and Law360's Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent.   

CONTACT:
Jonathan Naji, Esq.
280 King of Prussia Road
Radnor, PA 19087
(484) 270-1453
[email protected]

May be considered attorney advertising in certain jurisdictions.  Past results do not guarantee future outcomes.

SOURCE Kessler Topaz Meltzer & Check, LLP

powered by

AI infrastructure basket long (quality)

Buy a quality AI-infrastructure/semicap basket instead of CBRS—e.g., NVIDIA (NVDA) and Broadcom (AVGO). The news highlights that “AI infrastructure” winners are those that convert demand into cash; CBRS is priced for exceptional execution. Second-order effect: capital rotates toward firms with proven cash generation and lower execution risk as investors de-risk AI capex exposure.

Key Risk: AI demand shifts away from cash-generating incumbents toward newer infrastructure players, compressing NVDA/AVGO relative performance.

CBRS short

Sell Cerebras (CBRS). The DCF base case still implies overvaluation for risk-averse investors: even after the selloff, fair value is about $96 vs a much higher market price, and ~72% of value depends on terminal assumptions. The company must rapidly turn heavy AI infrastructure spending into durable free cash flow, which is exactly what has been missing so far.

Key Risk: They prove sustained free-cash-flow margins quickly (not just revenue), making the terminal-value assumptions conservative.

Cerebras Systems CBRS shares are extending losses on October 12th as investors continue to reassess the artificial intelligence (AI) infrastructure company’s future prospects.

CBRS is now trading at about half its price at the start of 2026, yet an illustrative discounted cash flow (DCF) analysis suggests it’s still overvalued for risk-averse investors.

For those interested in buying the dip in Cerebras stock, the central question is whether rapid sales expansion can ultimately translate into durable cash generation.

Cerebras Systems’ latest outlook targets $880 million – $890 million in 2026 core revenue, while management plans to more than triple revenue in 2027.

Its $25.4 billion in remaining performance obligations (RPOs) provides substantial visibility into contracted business, although those commitments are not equivalent to immediate cash flow.

DCF’s base case assumes “economic revenue” reaches $2.8 billion next year, $10.5 billion in 2031, and $19.2 billion by 2036.

It also assumes free cash flow (FCF) margin improves from negative 25% to positive 22% over that period.

While these assumptions aren’t official company forecasts, they’re still ambitious given Cerebras must absorb considerable investment needed to expand computing capacity before delivering cash to shareholders.

Discounting projected cash flows at 12% – with perpetual growth of 3% after 2036 – produces an estimated enterprise value of $21.2 billion.

Adding $6.2 billion in assumed adjusted net cash brings equity value to roughly $27.4 billion, and dividing that figure by an assumed 285 million diluted shares yields $96 fair value for CBRS stock.

The cash adjustment allows for spending after June, while the share count incorporates an allowance for warrants and employee equity. Neither represents a reported October balance-sheet figure.

Alternative scenarios demonstrate the uncertainty: weaker growth and profitability produce a value near $34 – while exceptional growth and a 30% terminal FCF margin support about $258 per share.

The DCF model suggests Cerebras shares look expensive under base assumptions, despite the selloff.

Holding margins, dilution, and discount rates constant, justifying $150.85 would require a revenue trajectory about 74% above the base case – reaching roughly$33 billion in 2036, alongside $7.3 billion in annual free cash flow.

Stronger margins or lower investment requirements could also support today’s valuation. However, about 72% of base-case enterprise value comes from the terminal value – making the result highly sensitive to distant expectations.

Investors should therefore treat $96 as a scenario estimate, rather than a precise price target.

In short, Cerebras Systems’ opportunity remains rather huge – but the company’s current price still demands considerable long-term success.

That said, Wall Street rates it at Buy currently, with a bullish mean price target of about $291.

Key Takeaways TSLA's Shanghai-built EV sales rose 5% y/y in September to 95,366 units, extending growth to 11 months.Shanghai-built EV sales climbed 13.7% in Q3, despite a 2.1% y/y decline in global deliveries. TSLA is offering discounts of up to 7,000 yuan on select models to boost demand. Tesla (TSLA - Free Report) reported a 5% year-over-year increase in sales of China-made electric vehicles (EVs) in September 2026, extending its annual growth streak to 11 months, per the China Passenger Car Association, as cited in Reuters. Deliveries of Model 3 and Model Y vehicles produced at its Shanghai factory, including exports to Europe, the Asia-Pacific and Canada, were 95,366 units compared with 90,812 units a year earlier.  

Shanghai-built EV sales rose 13.7% in the third quarter, according to Reuters calculations, although Tesla's global deliveries declined 2.1% year over year against a record-high comparable quarter in 2025. 

The September increase comes as Tesla faces intensifying competition in China, the world's largest automobile market.  

In September 2026, Tesla ranked sixth among new energy vehicle makers in China, trailing BYD, which led with 233,943 units. 

Tesla's Shanghai factory is helping the automaker offset demand pressure in China through stronger overseas shipments. The company is also offering final payment discounts through October, including 7,000 yuan on selected Model Y variants and 5,000 yuan across the Model 3 lineup, to encourage purchases in China's highly competitive EV market.  

These incentives, alongside product upgrades and Tesla's established manufacturing base, could help sustain sales momentum. However, continued discounting may weigh on automotive margins if lower prices are not offset by higher volumes and production efficiencies. 

Competitive Landscape: NIO & BYDDYRival Chinese automakers are also expanding their sales and strengthening their positions in the domestic and international EV markets.  

NIO Inc. (NIO - Free Report) delivered 37,408 vehicles in September 2026, up 7.7% year over year, across its NIO, ONVO and FIREFLY brands. Its flagship NIO brand delivered 21,318 vehicles, while FIREFLY deliveries reached a monthly record of 7,327 units. For the fiscal third quarter, total deliveries increased 25.4%, reflecting growing demand for its premium electric SUVs and smaller EV offerings.  

BYD Company Limited (BYDDY - Free Report) reported September sales of 463,561 new energy vehicles, up 17% year over year, marking its fifth consecutive month of sales growth, per Reuters. Its performance was supported by overseas expansion, with exports of passenger vehicles and pickups rising 153.9% to 179,877 units, helping offset subdued domestic demand. 

The Zacks Rundown for TeslaShares of TSLA are down 12.2% in a year against its industry's 0.8% fall.

Image Source: Zacks Investment Research

Tesla is currently trading at a forward 12-month price-to-sales of 13.08X, higher than the industry’s average of 3.39X. It carries a Value Score of D.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for TSLA for 2026 earnings implies year-over-year growth of 2.4%.

Image Source: Zacks Investment Research

The consensus estimate for EPS for fiscal 2026 has been moving southward over the past 60 days.

Image Source: Zacks Investment Research

TSLA currently has a Zacks Rank of #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Jefferies has raised its price target for Tesla Inc (NASDAQ:TSLA), the electric carmaker, to $400 from $350, as resilient vehicle deliveries and improving prospects for non-automotive businesses offset concerns over rising investment and operating costs.

Analyst Philippe Houchois maintained a 'hold' rating, with the revised target implying 5% upside from Tesla’s closing price of $382.70 cited in the 12 October research note.

Jefferies expects third-quarter revenue of $29.2 billion, an automotive gross margin of 16.7% and adjusted operating profit of $781 million, while forecasting cash outflow of about $5 billion.

Tesla delivered 486,532 vehicles during the quarter, up 1% from the previous three months but down 2% year on year, with its Model 3 and Model Y accounting for 478,200 deliveries.

The broker said demand across China, Europe and the United States had proved resilient, reflecting Tesla’s competitive value for money as well as lower comparison figures in some markets and higher fuel costs in Europe.

Production reached 464,400 vehicles, leaving output below deliveries, although Jefferies expects year-to-date production and deliveries to remain broadly aligned and support working capital.

The broker forecast automotive revenue of $21 billion, with a limited contribution of $140 million from regulatory credits, while stronger software uptake and improved vehicle resale values could support margins.

However, sustained research and development and selling costs are expected to weigh on profitability, while capital expenditure of $8 billion underpins Jefferies’ forecast of substantial cash outflow.

Jefferies has cut longer-term estimates because of the limited range of new vehicle models, slower energy-storage growth and the likelihood that newer ventures will initially generate losses.

The bank nevertheless sees improving prospects for full self-driving software, energy storage and robotaxis, while Tesla’s semi-truck programme is moving into production despite limited visibility over orders.

Houchois also highlighted the possibility of a future merger with SpaceX Corp (NASDAQ:SPCX), arguing that overlapping technology ambitions, investment requirements and Elon Musk’s preference for retaining control could strengthen the strategic case.

The price-target increase therefore reflects potential value from Tesla’s broader technology ambitions rather than a clear improvement in its near-term earnings outlook.

Alphabet's cloud backlog just hit $514 billion and CEO Sundar Pichai is growing more bullish by the day, yet the stock barely budged. Here is what has to happen for shares to double by 2030.

Alphabet (NASDAQ:GOOG | GOOG Price Prediction | GOOG Price Prediction) runs Google Search and YouTube, and it now also runs one of the fastest-growing clouds on the planet. Google Cloud revenue rose 82% to $24.77 billion last quarter, and backlog reached $514 billion.

Yet the stock is up just 10.59% year to date. The business is speeding up while the stock stalls. CEO Sundar Pichai said “over the past year, we’ve gotten more bullish on the opportunities ahead.” So can Alphabet hit $700 by 2030?

What’s Holding Alphabet Back Right Now The issue is cash. Capex hit $44.92 billion in Q2, up 100.14%, and free cash flow turned to negative $5.86 billion. Long-term debt climbed from $46.5 billion to $98.2 billion, and the buyback was suspended. Shares fell 6.89% on earnings day despite a huge EPS beat.

Momentum since then is modest: up 1.64% over a week and 3.29% over a month, still below the $403.96 52-week high. A beta of 1.211 means swings run larger than the market. Until spending turns into visible free cash flow, shares may stay range-bound.

Wall Street Sees 21% Upside. Our Model Says 26% The consensus target is $419.65, about 21.2% upside, backed by 13 strong buys, 42 buys, 5 holds and zero sells. The base case sits at $436.85, or 26.39% upside, with a range of $369.53 to $454.13. Model confidence of 0.7 signals solid but measured conviction.

The long-term view looks too conservative. Analysts are 92% bullish, and earnings growth adds a 0.03 contribution to our model, yet the five-year base case only reaches $685.35 by October 2031. A $514 billion backlog argues for more.

Here’s What It Takes for Alphabet to Reach $700 A climb to $700 from today’s price of $346.34 would require a gain of 102.1%.

With 2027 consensus EPS of $15.0715, $700 would mean a forward P/E of 46x. The base case of $436.85 already implies 29x, so the bold target requires 17x of additional multiple expansion.

That looks steep, and time is what fixes it. If EPS compounds 15% a year after 2027, 2030 earnings reach roughly $22.92, and $700 falls to about 31x. The 1.12 adjustment factor reflects strong consensus and earnings acceleration.

The catalysts are concrete. Alphabet expects to recognize just over 50% of the backlog within 24 months. TPU system revenue ramps as Alphabet exits 2026, with most of it landing in 2027.

All of that compute has to be powered, cooled, and networked by somebody, and we rounded up seven of those suppliers in a free AI infrastructure report.

The Gemini app has 950 million monthly users, and Google just launched a Gemini AI agent to compete with OpenAI and Microsoft. Pichai added, “We are now training Gemini 4, and we’ve been very ambitious with it.” The biggest risk is that capex keeps outpacing returns and drags down free cash flow for years.

Where Alphabet Trades Today vs. Its Earnings Power At $346.34, shares trade at about 23x 2027 estimates. With revenue growing 24.23% and operating margin at 34%, that multiple looks cheap.

Shares sit between a $236.07 low and a $403.96 high. Over ten years, the stock has returned 802.2%. Today’s reasonable multiple leaves room for the upside scenario to play out.

Is $700 Realistic? Here’s My Take A move to $700 would take a 102.1% gain. My verdict: it’s a stretch, but it can be done by 2030.

Three things would need to go right. Cloud backlog has to convert on schedule, free cash flow has to turn positive again once the expansion is completed, and Gemini 4 has to keep Google at the frontier. A sharp decline in AI demand would disrupt it. Gains like this won’t happen every year, but we’ve outlined the blueprint for how Alphabet could reach $700 in 2030.

Contact [email protected] for any questions or corrections.

AMD has surged 184% this year and now trades above $600, but the real question is whether its Helios chip ramp can grow into that valuation before the market loses patience with a 155x trailing multiple.

AMD (NASDAQ:AMD | AMD Price Prediction) trades at $608.10 after pushing past $600. The price is a waypoint for AMD, and investors should not read it as a ceiling, since the stock is up 183.95% year to date and earnings estimates keep rising behind it.

AMD designs CPUs, GPUs and AI accelerators. It competes with NVIDIA (NASDAQ:NVDA) in AI chips. Data Center revenue reached $6.72 billion last quarter, up 107% year over year and now 58% of total sales. The stock traded at $222.50 when AMD reported Q4 FY2025 and at $494.60 when it reported Q2 FY2026.

Gigawatt Deals Lock In a Multi-Year AI Runway AMD guided Q3 revenue to about $13B +/- $300M, which works out to around 41% growth. Behind that guide sit multi-gigawatt customer commitments: OpenAI at 6 gigawatts, Meta Platforms (NASDAQ:META) at up to 6 GW and Anthropic at up to 2 GW. Management expects Data Center revenue to “more than double year-over-year in 2027”.

Analysts have raised their numbers to match. The 2027 EPS consensus is now $15.7219, up from $13.1993 90 days ago. That puts the stock near 39x 2027 earnings, with a PEG ratio of 0.626.

A 155x Trailing Multiple Punishes Any Stumble On trailing numbers, AMD’s earnings multiple stands at 155 and its free cash flow multiple is 148. Free cash flow fell 9.89% in Q2 as capex rose 186.52%. Gaming revenue dropped 31%, and management expects PC demand to soften as memory costs rise.

Export controls already cost AMD an $800M MI308 inventory charge. NVIDIA still dominates AI accelerators, and the gigawatt deals are future installations that have not yet become booked revenue. With a beta of 2.454, the stock fell 4.07% last week while the S&P 500 rose 1.16%.

Helios Yields Will Set the Next Leg Management called Helios “highly complex” and expects yields to improve over the first few quarters of the ramp. AI GPUs also carry gross margins “slightly below corporate average,” which puts the 56% margin guide at risk. Forecasts for 2027 revenue run from about $61 billion to $118 billion, and Q3 and Q4 results should help narrow that range.

Stock Outruns Wall Street and the S&P 500 The consensus target of $636.21 points to a 4.6% gain from $608.10. Targets have fell behind this rally. Among 55 analysts:

Strong Buy: 5 Buy: 39 Hold: 11 Sell: 0 AMD is up 183.95% year to date, against 14.17% for the S&P 500. Over one year it gained 161.11%, versus a 16% rise for the index. Shares sit 7.7% below the $658.52 high and well above the 50-day average of $528.92. The forward P/E is 40.

Can 2027 Earnings Catch Up to AMD’s $600 Price? At $608.10, AMD’s valuation depends on executing the Helios ramp.

The path higher runs through the Helios ramp. Management said “Q4 is a step up” and “Q1 will be a further step up.” Anthropic’s first gigawatt is scheduled to start deploying in the first half of 2027. Each quarter that confirms the ramp should pull 2027 estimates higher and bring the multiple down.

Chair and CEO Lisa Su said, “We are still in the early stages of a multi-year AI adoption cycle.” AMD also expects to “significantly exceed our $20 annual EPS target.” If it gets there, the multiple on future earnings would contract (we reverse-engineered the traits the biggest chip winners shared before their runs in a free playbook here: The Next Nvidia Playbook).

The thesis breaks if Helios shipments slip, if gross margin falls below 56%, or if new export rules hit Instinct sales. Hyperscaler capex cuts would also force a review.

At 39x 2027 earnings, AMD’s run past $600 depends on Helios delivering that growth.

Contact [email protected] for any questions or corrections.

NVIDIA just doubled its revenue per gigawatt of AI capacity and posted triple-digit earnings growth, yet its stock has struggled to keep pace with the profits. A $350 price target sounds ambitious until you see what the math actually requires.

NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) now makes about $40 billion per gigawatt of AI capacity built on Vera Rubin, up from roughly $18 billion with Hopper. That shift is a big reason a company worth about $5.76 trillion may still have room to grow.

Shares are up 27.67% year to date. Over the same stretch, quarterly earnings grew 127.8% year over year. The stock has fallen behind the profits. So can NVIDIA reach $350 by October 2027?

What’s Holding NVIDIA Back Right Now
The stock gained 4.55% over the past week and 3.23% over the past month, modest moves for a business that just reported quarterly revenue of $96.22B, up 105.8%. Supply is the main constraint.

On the August call, management said, “Our entire supply chain is challenged.” Gross margin was 75% in Q2, but management expects 71% to 72% in Q4 because memory prices are rising. With a beta of 2.216, the stock swings about twice as much as the broader market.

Wall Street Sees 37% Upside, and I Think That’s Closer to Right
The consensus target is $328.72, or 37.4% upside. Ratings stand at 10 Strong Buys, 48 Buys, 2 Holds and 1 Sell. Our model is more cautious, with a base case of $276.74 (15.67% upside). Its range runs from $237.97 to $323.41, and it carries high confidence.

I think the model is too conservative. It cuts its adjustment in half because of NVIDIA’s size and gives earnings growth only a 0.03 contribution. Meanwhile, 95% of analysts are bullish, and fiscal 2028 EPS estimates got 46 upward revisions and zero cuts in the past 30 days.

Here’s What It Takes for NVIDIA to Reach $350
Reaching $350 from today’s price of $239.24 would require a gain of 46.3%.

With forward EPS of $13.0631, a price of $350 implies a forward P/E of 27x. Our base case already implies 34x on the model’s own math, so the $350 target actually sits 7 turns below that figure. Compared with today’s forward multiple, though, it needs about 8 turns of expansion.

I think that expansion is possible. Our 1.14 adjustment factor reflects a 1.15 technology sector multiplier and strong analyst support. Earnings growth also brings the multiple down quickly.

Based on fiscal 2028 consensus EPS of $15.6951, $350 works out to just 22x. Management expects about 70% revenue growth in fiscal 2028, even with supply limits.

The top five hyperscalers are expected to grow capex from nearly 800 billion in 2026 to 1.3 trillion in 2027. Jensen Huang said, “AI has reached its inflection point. It’s doing useful work. Its tokens are productive and profitable. Now, compute is revenue.”

The main risk is NVIDIA’s $279B in supply commitments, which would turn into a burden if AI spending pauses. That same expansion also runs through the power, cooling, and networking suppliers we profiled in a free report on seven AI infrastructure stocks that aren’t chipmakers.

Where NVIDIA Trades Today vs. Its Earnings Power
The stock trades at about 18x forward earnings, cheap for a company expecting growth near 70%.

Shares sit near the top of their 52-week range of $163.90 to $240.10, and the stock has returned 14383.2% over the past 10 years. Since the multiple has declined while earnings kept growing, there is room for the bull case to play out.

$350 Is a Stretch, but Here’s Why It’s Possible
Hitting $350 requires a 46.3% gain. I see it as a stretch, though an possible one. Supply has to ease, gross margins have to hold in the 72% to 73% range for fiscal 2028, and Vera Rubin has to deliver what management calls “the fastest product ramp in NVIDIA’s history.” A broad decline in hyperscaler spending would undermine the thesis.

Returns at this level shouldn’t be expected every year, but we’ve outlined the blueprint for how NVIDIA could reach $350 in 2027.

Contact [email protected] for any questions or corrections.

Netflix Inc. (NASDAQ:NFLX) shares are in the spotlight Monday, with earnings on deck, advertising and revenue growth in focus, recent analyst activity and a technical setup showing the stock trying to stabilize under its 20-day average.

Earnings Preview & HistoryNetflix is scheduled to report third-quarter earnings on Oct. 20 after the market closes. Analysts estimate earnings per share of 82 cents along with revenue of $12.88 billion. For the prior quarter, Netflix reported earnings per share of 80 cents, beating the consensus estimate of 79 cents. The company also posted revenue of $12.56 billion, missing the consensus estimate of $12.59 billion.

What to Watch: Revenue Growth, Advertising and MarginsInvestors will be closely tracking revenue growth against Netflix’s third-quarter guidance of about $12.86 billion, or roughly 12% growth, after second-quarter growth slowed to 11% on an FX-neutral basis. Advertising will also be in focus, with S&P Global estimating second-quarter ad revenue at $618 million, up almost 80% from a year earlier but below expectations. Management’s operating margin guidance of 33.2% and its outlook for the rest of the year, including content spending that is expected to rise about 10% in 2026, should offer additional signals.

Analyst Consensus & Recent Actions The stock carries a Buy rating with an average price forecast of $89.30. Recent analyst moves include:

Morgan Stanley: Overweight (Lowers Target to $80.00) (Oct. 8) Barclays: Equal-Weight (Lowers Target to $70.00) (Oct. 7) TD Cowen: Buy (Maintains Target to $100.00) (Oct. 5) Netflix Tries to Stabilize Under Its 20-Day AverageFrom a longer-term trend view, Netflix is still in a downtrend: the stock is trading 14.6% below its 200-day SMA ($83.45) and 42.33% lower over the past 12 months. It’s also trading 5.4% below its 50-day SMA ($75.33), keeping rallies vulnerable to selling pressure near overhead averages.

Near term, price is trying to stabilize just under the 20-day SMA ($71.66) and 20-day EMA ($71.49), which is often where "make-or-break" decisions happen for swing traders. If the stock can reclaim and hold above those short-term measures, it can shift the conversation from "bounce" to "base."

Momentum is improving on the MACD: it’s above its signal line and the histogram is positive, which suggests downside pressure is easing versus the prior downswing. In plain terms, when MACD is above its signal line, it often means the recent selling wave is losing control even if the bigger trend hasn’t fully turned.

Key levels are tight right now, which can amplify moves if either side breaks.

Key Resistance: $82.50 — a nearby ceiling that lines up with an area where rebounds can stall well below the 200-day average Key Support: $70.50 — a close-by floor near the current price zone where buyers have recently been willing to defend Read Next

Netflix Shares Edge HigherNFLX Price Action: At the time of publication, Netflix shares are trading 1.37% higher at $71.26, according to data from Benzinga Pro.

Image via Shutterstock

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.